NUBEQA 300 mg, Filmtabletten - 112 Swissmedic Key 67521001 Registration Holder Bayer (Schweiz) AG Name NUBEQA 300 mg, Filmtabletten Date of registration 19.06.2020 Introduction of Sequence 19.06.2020 ATC-Classification Darolutamide (L02BB06) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.16.20. Show package size 112 Index Therapeuticus (Swissmedic) 07.16.20. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 2930.21 Limitation Yes Limitation text
Deductible 10 % Consumer price 3203.20 Feedback FB Daily cost GTIN 7680675210015 Medication Code Synthetika Pharmacode Disponibility
Composition darolutamidum 300 mg, calcii hydrogenophosphas, carmellosum natricum conexum corresp. natrium 2.7 mg, lactosum monohydricum, magnesii stearas, povidonum K 30, Überzug: hypromellosum, lactosum monohydricum, macrogolum 3350, E 171, pro compresso obducto corresp. lactosum monohydricum 186 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Darolutamidum 300 mg
BAG: Active Agent Dose Darolutamidum 300 mg
Inactive agents Dose additional_information Calcium Hydrogen Phosphate Carmellosum Natricum Conexum E 171 color. Hypromellosum Überzug Lactose Monohydrate Macrogol 3350 Magnesii Stearas Povidonum K 30 Pro Compresso Obducto
Source Data was imported : 07.08.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
